申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US07060721B1
公开(公告)日:2006-06-13
Imidazole compounds represented by general formula (I):
wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy inhibitory action.
提供一般式(I)所代表的咪唑化合物:
其中每个符号如规范中定义的那样,并且其盐,以及包含它们的药物组合物。这些化合物对于治疗基于降血糖作用可治愈的疾病和基于cGMP-PDE抑制作用、平滑肌松弛作用、支气管扩张作用、血管扩张作用、平滑肌细胞抑制作用和过敏抑制作用可治愈的疾病非常有用。